The total return over the past 12 months is -82.46% vs. +16.94% for the S&P 500. So far it's up -75.88% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (82.46%) | N/A | N/A | N/A | N/A | N/A |
| Total Return CAGR | (82.46%) | N/A | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Elicio Therapeutics, Inc. (ELTX)
| Year | Start price | End price | ELTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $7.96 | $1.92 | (75.88%) | +14.51% | (90.39%) |
| 2025 | $5.10 | $7.96 | +56.08% | +17.72% | +38.36% |
| 2024 | $8.34 | $5.10 | (38.85%) | +24.89% | (63.74%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
